Cardiovascular Risk Management: An Overview
Cardiovascular disease (CVD) is a leading cause of mortality and is responsible for one-third of all global deaths annually. This translates into the deaths of 17 million people each year [1, 2]. Despite research-based gains in the treatment of CVDs, they remain the leading killer in the USA and in most developed areas of the world. Coronary heart disease (CHD) accounts for the majority of CVD deaths, disproportionately afflicts racial and ethnic minorities, and is a prime target for prevention. Hypertension is the most prevalent CVD, affecting at least 600 million people, and is an important contributor to cardiovascular mortality and morbidity . Nearly 85% of the global mortality and disease burden from CVD is borne by low- and middle-income countries.
KeywordsImpaired Glucose Regulation Single Risk Factor Audit Standard mmHg Diastolic mmHg Systolic
Unable to display preview. Download preview PDF.
- 1.Mathers CD, Stein C, Ma Fat DM et al (2002) Global burden of disease 2000. Version 2: methods and results. World Health Organization, GenevaGoogle Scholar
- 2.World Health Organization (2002) The World Health Report 2002 ‘Reducing risks and promoting healthy life’. World Health Organization, GenevaGoogle Scholar
- 6.Alwan A, Maclean D, Mandil A (2001) Assessment of national capacity for noncom-municable disease prevention and control. The report of a global survey. World Health Organization, GenevaGoogle Scholar
- 7.World Health Organization (2001) Innovative care for chronic conditions. World Health Organization, GenevaGoogle Scholar
- 12.World Health Organization (2001) Adherence to long-term therapies: policy for action. World Health Organization, GenevaGoogle Scholar
- 13.Feldman R, Bacher M, Campbell N, Drover A, Chockalingam A (1998) Adherence to pharmacologic management of hypertension. Can J Public Health 89(5):116–118Google Scholar